Cancer Case Studies Flashcards

1
Q

Chronic Myeloid leukaemia presentation

A

No clinical symptoms
good health
Splenomegaly (palpable)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

CML cells of origin

A

Neutrophil
Eosinophil
Basophil (mast cell)
Platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

CML incidence

A

1.5 in 100,000 per year

675 new diagnosis UK 2011

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Tyrosine Kinase Inhibitors (TKIs) 1st generation

A

Imatinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

TKI 2nd generation

A

Nilotinib

Dasatinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

TKI 3rd generation

A

Ponatinib

Bosutinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CML Treatment algorithm

A

1st or 2nd generation TKI
If no response, 2nd generation TKI
Then allogeneic stem cell transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hodgkins Classification

A

It is a Lymphoid neoplasm
Hodgkin Lymphoma
Non-Hodgkins Lymphoma (B Cell or T Cell)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

B Cell non Hodgkins Lymphoma

A

Aggressive or Indolent
Aggressive- rapid, treat with chemo
Indolent- slow, watch and wait, patient asymptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Chemoimmunotherapy- used against Lymphoid neoplasms

A

Cytostatic drugs + targeted immunotherapy (Rituximab)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Thalidomide

Lenalidomide

A

Anti-proliferative
Co-stimulation of T cells + NK cell activation
Anti-angiogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Bortezomib

A

Proteasome inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Temsirolimus

A

mTOR inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly